Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain

This Medical News article discusses the reasons behind the burgeoning black market for 2 unapproved GLP-1 weight loss drugs and the potential risks associated with their use.

Authors

Publication Details

Journal
JAMA
Published
2026-10-09
DOI
https://doi.org/10.1001/jama.2026.20514
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain

Rita Rubin
JAMA
Pharmaceutical Quality and Counterfeiting
article

Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain

Rita Rubin
article en

Abstract

This Medical News article discusses the reasons behind the burgeoning black market for 2 unapproved GLP-1 weight loss drugs and the potential risks associated with their use.

JAMA
Openalex Percentile: Top 10%
Pharmaceutical Quality and Counterfeiting
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain — Rita Rubin · JAMA (2026) | TGRS Research Map | TGRS